Risperdal adds to DePuy and Ethicon Troubles for J&J

Johnson and Johnson (J&J), already embroiled in massive litigation in DePuy ASR artificial hips, and in the trans vaginal mesh litigation from its Ethicon Gynecare products, faces another significant issue over its mounting legal troubles stemming from its antipsychotic drug Risperdal.  The drug was approved in 1993 for use in adults and was also later [...]